Key result
Urinary TIMP-2 and IGFBP-7*TIMP-2 levels were significantly higher in critically ill children at risk for AKI compared to controls, indicating their potential as predictors of AKI risk.
Why the study?
Acute kidney injury is prevalent in critically sick paediatric patients, and this study aimed to assess the role of urinary TIMP-2 * IGFBP-7 as an early predictor of AKI in critically ill children.
Do urinary TIMP-2 and IGFBP-7 levels predict acute kidney injury in critically ill children in the pediatric intensive care unit?
Case-Control
Do urinary TIMP-2 and IGFBP-7 levels predict acute kidney injury in critically ill children in the pediatric intensive care unit?
Urinary IGFBP-7*TIMP-2 levels may serve as an early predictor of acute kidney injury risk in critically ill pediatric patients, though they do not correlate with mortality or ICU length of stay.
May aid early AKI risk identification in pediatric ICU; hypothesis-generating pending prospective validation.
Background: Acute kidney injury (AKI) is more prevalent in critically sick paediatric patients owing to variables like mechanical ventilation, severe infection and nephrotoxic medications. This study aimed to assess urinary TIMP-2 * IGFBP-7 role as an earlier predictor of AKI in critically ill children. Methods: This is case control study included pediatric patients admitted to PICU and at risk for AKI (Group I) and age- and sex- matching control group (Group II) which was split into 2 subgroups: Group II A that included children admitted to PICU without risk of AKI and Group II B as a control group that included healthy children not admitted to PICU. Children were exposed to a comprehensive history taking, clinical examination, and laboratory examinations. Two urine sample 48 hour apart for urinary tissue inhibitor of metalloproteinase-2 (TIMP-2), insulin-like growth factor binding protein-7 (IGFBP-7). Results: Cases with risk of AKI showed significantly higher TIMP2 and IGFBP7*TIMP2 those were the substantial AKI predictors, whereas no substantial change was seen among the groups in IGFBP7 levels. The described markers showed no significant differences according to the AKI etiological factors, long term outcome, AKI 30-day mortality or ICU stay length (p>0.05). Conclusions; The levels of IGFBP-7*TIMP-2 marker in the critically-ill pediatric population could be a predictor of AKI risk. The studied markers did not show significant difference according to the mortality. Moreover, they did not show significant correlation with ICU stay length.
No takes yet. Share an insight, caveat, or question.
Sobeih et al. (2023) conducted a case-control in Acute kidney injury. Urinary TIMP-2 and IGFBP-7 levels vs. Age- and sex-matched controls (PICU patients without AKI risk and healthy children) was evaluated on Prediction of AKI risk. Urinary TIMP-2 and IGFBP-7*TIMP-2 levels were significantly higher in critically ill children at risk for AKI compared to controls, indicating their potential as predictors of AKI risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: